Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Cell Sci ; 119(Pt 23): 4986-93, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-17105769

ABSTRACT

The biological mechanisms underlying the mental retardation associated with mutation of the ARHGEF6 gene, a Rac1/Cdc42 exchange factor, are still unknown, although defects in the plasticity of synaptic networks have been postulated. We have cloned the rat ARHGEF6 gene and investigated, using a transfection approach, its involvement in spine morphogenesis and its relationship to p21-activated kinase 3 (PAK3). We found that expression of tagged ARHGEF6 in hippocampal slice cultures shows a punctate staining in dendritic spines that colocalizes with PSD95. Over-expression of ARHGEF6, of PAK3 or constitutively active PAK3 did not alter spine morphology. By contrast, knockdown of ARHGEF6 using a siRNA approach resulted in abnormalities in spine morphology similar to those reported with knockdown of PAK3. This phenotype could be rescued through co-expression of a constitutively active PAK3 protein, but not with wild-type PAK3. Together, these results indicate that ARHGEF6 is localized in dendritic spines where it contributes to regulate spine morphogenesis probably by acting through a downstream activation of PAK3. Similar mechanisms are thus likely to underlie the mental retardation induced by mutations of ARHGEF6 and PAK3.


Subject(s)
Cell Cycle Proteins/physiology , Dendritic Spines/genetics , Guanine Nucleotide Exchange Factors/physiology , Protein Serine-Threonine Kinases/physiology , Animals , Cell Cycle Proteins/antagonists & inhibitors , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Dendritic Spines/metabolism , Guanine Nucleotide Exchange Factors/antagonists & inhibitors , Guanine Nucleotide Exchange Factors/genetics , Guanine Nucleotide Exchange Factors/metabolism , Hippocampus/cytology , Hippocampus/metabolism , Intellectual Disability/genetics , Mice , NIH 3T3 Cells , Phenotype , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA, Small Interfering/pharmacology , Rats , Rho Guanine Nucleotide Exchange Factors , Time Factors , Tissue Culture Techniques , Transfection , p21-Activated Kinases
2.
J Neurosci ; 24(48): 10816-25, 2004 Dec 01.
Article in English | MEDLINE | ID: mdl-15574732

ABSTRACT

Mutations of the gene coding for PAK3 (p21-activated kinase 3) are associated with X-linked, nonsyndromic forms of mental retardation (MRX) in which the only distinctive clinical feature is the cognitive deficit. The mechanisms through which PAK3 mutation produces the mental handicap remain unclear, although an involvement in the mechanisms that regulate the formation or plasticity of synaptic networks has been proposed. Here we show, using a transient transfection approach, that antisense and small interfering RNA-mediated suppression of PAK3 or expression of a dominant-negative PAK3 carrying the human MRX30 mutation in rat hippocampal organotypic slice cultures results in the formation of abnormally elongated dendritic spines and filopodia-like protrusions and a decrease in mature spine synapses. Ultrastructural analysis of the changes induced by expression of PAK3 carrying the MRX30 mutation reveals that many elongated spines fail to express postsynaptic densities or contact presynaptic terminals. These defects are associated with a reduced spontaneous activity, altered expression of AMPA-type glutamate receptors, and defective long-term potentiation. Together, these data identify PAK3 as a key regulator of synapse formation and plasticity in the hippocampus and support interpretations that these defects might contribute to the cognitive deficits underlying this form of mental retardation.


Subject(s)
Mental Retardation, X-Linked/genetics , Protein Serine-Threonine Kinases/physiology , Amino Acid Substitution , Animals , Biolistics , Cell Line, Tumor/ultrastructure , Codon, Nonsense , Cognition Disorders/genetics , Cognition Disorders/physiopathology , Dendrites/ultrastructure , Genes, Dominant , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/ultrastructure , Humans , Long-Term Potentiation , Mental Retardation, X-Linked/physiopathology , Mental Retardation, X-Linked/psychology , Mice , Morphogenesis , Mutation, Missense , NIH 3T3 Cells , Neuroblastoma/pathology , Organ Culture Techniques , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/deficiency , Protein Serine-Threonine Kinases/genetics , Protein Structure, Tertiary , Pseudopodia/ultrastructure , Pyramidal Cells/physiology , RNA, Antisense/pharmacology , RNA, Antisense/toxicity , RNA, Small Interfering/pharmacology , RNA, Small Interfering/toxicity , Rats , Receptors, AMPA/deficiency , Recombinant Fusion Proteins/physiology , Transfection , p21-Activated Kinases
SELECTION OF CITATIONS
SEARCH DETAIL